Work

Final Results from the Multicenter, Open-Label, Phase II GIBB Study of Obinutuzumab+Bendamustine in Previously Untreated Patients with Chronic Lymphocytic Leukemia

Year: 2019

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2019-122482

Authors: Jeff P. Sharman, John M Burke, Habte A Yimer, Michael A. Boxer, Sunil Babu, Jia Li, Yong Mun, Alexey Danilov

Institutions: Willamette Valley Cancer Institute and Research Center, Rocky Mountain Cancer Centers, Texas Oncology, Arizona Oncology, Fort Wayne Medical Institute, Genentech, Oregon Health & Science University, OHSU Knight Cancer Institute

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2989071867

Cites:

Cited by: 1

Related to: 10